Mdm2 inhibitors synergize with topoisomerase II inhibitors to induce p53‐independent pancreatic cancer cell death. Issue 10 (26th November 2012)
- Record Type:
- Journal Article
- Title:
- Mdm2 inhibitors synergize with topoisomerase II inhibitors to induce p53‐independent pancreatic cancer cell death. Issue 10 (26th November 2012)
- Main Title:
- Mdm2 inhibitors synergize with topoisomerase II inhibitors to induce p53‐independent pancreatic cancer cell death
- Authors:
- Conradt, Laura
Henrich, Annika
Wirth, Matthias
Reichert, Maximilian
Lesina, Marina
Algül, Hana
Schmid, Roland M.
Krämer, Oliver H.
Saur, Dieter
Schneider, Günter - Abstract:
- <abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <p>Pancreatic ductal adenocarcinoma (PDAC) represents the fourth leading cause of cancer death in the western world, with a 5‐year survival rate below 5%. Murine double minute 2 (Mdm2) is an important negative regulator of the tumor suppressor p53. Reactivation of wild‐type <italic>p53</italic> is a promising treatment strategy, and inhibitors of Mdm2 have already entered clinical trials. To investigate the effects of Mdm2 inhibitors in PDAC, we used a murine cell line platform with a genetically defined status of <italic>p53</italic>. Here, we describe that Mdm2 inhibitors can act on a subset of murine PDAC cell lines p53 independently. Furthermore, we observed that Mdm2 inhibitors increase the sensitivity of murine PDAC cell lines toward topoisomerase II inhibitors by inducing effector caspase‐independent cell death. The combination of Mdm2 inhibitors with topoisomerase II inhibitors acts independent of the survival factor NFκB/RelA. Mechanistically, Mdm2 inhibitors increase topoisomerase II inhibitor‐induced DNA double‐strand breaks. We show that Mdm2 binds to Nbs1 of the Mre11–Rad50–Nijmegen breakage syndrome (Nbs) 1 DNA repair complex. In addition, we provide evidence that Mdm2 inhibitors delay DNA repair. These findings may help to design novel therapeutic strategies to overcome therapeutic resistance of PDAC.</p> </abstract>
- Is Part Of:
- International journal of cancer. Volume 132:Issue 10(2013:May 15)
- Journal:
- International journal of cancer
- Issue:
- Volume 132:Issue 10(2013:May 15)
- Issue Display:
- Volume 132, Issue 10 (2013)
- Year:
- 2013
- Volume:
- 132
- Issue:
- 10
- Issue Sort Value:
- 2013-0132-0010-0000
- Page Start:
- 2248
- Page End:
- 2257
- Publication Date:
- 2012-11-26
- Subjects:
- Cancer -- Periodicals
Cancer -- Prevention -- Periodicals
616.994 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0215 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/ijc.27916 ↗
- Languages:
- English
- ISSNs:
- 0020-7136
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.156000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4199.xml